Study on risk reducing bilateral salpingo-oophorectomy (RRSO) for BRCA1/2 mutation carriers

Study on risk reducing bilateral salpingo-oophorectomy (RRSO) for BRCA1/2 mutation carriers - Study on RRSO for BRCA1/2 mutation carriers

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018302

Enrollment

Registered

2015-08-01

Start date

2015-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary breast and ovarian cancer

Interventions

risk reducing salpingo-oophorectomy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. BRCA1/2 mutant carriers 2. Informed consent

Exclusion criteria

Exclusion criteria: 1. Women who diseres having babies 2. Women with ovarian or tubal cancer 3. Physician decision

Design outcomes

Primary

Measure	Time frame
Perioperative complications related to risk reducing salpingo-oophorectomy	—

Countries

Japan

Contacts

Public ContactAyako Kawabata

The Jikei university, school of medicine Department of Obstetrics and Gynecology

ayakokawabata0702@jikei.ac.jp+81-3-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026